20/11/2024
Sarah Sinclair
Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer term plans to phase out flower-based products altogether.
As of January 2025, patients in Luxembourg will no longer be able to access cannabis flower containing high levels of THC on prescription, according to the country’s Health Minister.
There are also reports of plans to restrict access to high-CBD cannabis flower in the future, leaving only oils and other formats of cannabis-based medications available for therapeutic use.
A law allowing personal possession of non-medical cannabis and the cultivation of up to four plants per household for personal consumption approved in June 2023 will not be affected by the proposals.
Medical cannabis has been legal in Luxembourg under strict regulations since 2018 and is currently prescribed for advanced or terminal chronic conditions causing severe and untreatable pain, chemotherapy-induced nausea or vomiting as part of cancer treatment and muscle spasticity associated with multiple sclerosis.
